Non inferiority efficacy analysis of natalizumab subcutaneous versus intra venous administration

1. júla 2023 1 videnie
Mealli F et al.
2012 - 2025 Copyright Farmi-Profi, spol. s r.o - Všetky práva vyhradené - Made by Elite ML